Magnesium sulfate and fetal neuroprotection: overview of clinical evidence

Magnesium sulfate and fetal neuroprotection: overview of clinical evidence

Antenatal administration of magnesium sulfate is an important part of the neuroprotective strategy for preterm infants. Strong evidence from five randomized controlled trials and five meta-analyses has demonstrated that magnesium sulfate, when administered before preterm delivery, significantly redu...

Full description

Bibliographic Details
Main Authors: Clément Chollat, Stéphane Marret
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2018-01-01
Series:Neural Regeneration Research
Subjects:
magnesium sulfate; preterm birth; neuroprotection; cerebral palsy; neurodevelopment; international recommendations; clinical studies; meta-analysis; preeclampsia; cost-effectiveness
Online Access:http://www.nrronline.org/article.asp?issn=1673-5374;year=2018;volume=13;issue=12;spage=2044;epage=2049;aulast=Chollat

Internet

http://www.nrronline.org/article.asp?issn=1673-5374;year=2018;volume=13;issue=12;spage=2044;epage=2049;aulast=Chollat

Similar Items